- Home
- WNEB vs INBX Comparison
WNEB vs INBX Comparison
Compare WNEB & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNEB
- INBX
- Stock Information
- Founded
- WNEB 1853
- INBX 2010
- Country
- WNEB United States
- INBX United States
- Employees
- WNEB N/A
- INBX N/A
- Industry
- WNEB Savings Institutions
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- WNEB Finance
- INBX Health Care
- Exchange
- WNEB Nasdaq
- INBX Nasdaq
- Market Cap
- WNEB 165.5M
- INBX 232.2M
- IPO Year
- WNEB N/A
- INBX 2020
- Fundamental
- Price
- WNEB $8.90
- INBX $15.36
- Analyst Decision
- WNEB Hold
- INBX Hold
- Analyst Count
- WNEB 4
- INBX 1
- Target Price
- WNEB $8.50
- INBX N/A
- AVG Volume (30 Days)
- WNEB 39.9K
- INBX 103.6K
- Earning Date
- WNEB 10-22-2024
- INBX 08-13-2024
- Dividend Yield
- WNEB 3.23%
- INBX N/A
- EPS Growth
- WNEB N/A
- INBX N/A
- EPS
- WNEB 0.63
- INBX 118.83
- Revenue
- WNEB $74,435,000.00
- INBX $1,687,000.00
- Revenue This Year
- WNEB N/A
- INBX N/A
- Revenue Next Year
- WNEB $5.16
- INBX N/A
- P/E Ratio
- WNEB $13.68
- INBX $0.13
- Revenue Growth
- WNEB N/A
- INBX 24.26
- 52 Week Low
- WNEB $6.00
- INBX $10.80
- 52 Week High
- WNEB $9.25
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- WNEB 59.33
- INBX 63.81
- Support Level
- WNEB $8.45
- INBX $14.51
- Resistance Level
- WNEB $8.99
- INBX $15.63
- Average True Range (ATR)
- WNEB 0.18
- INBX 0.72
- MACD
- WNEB -0.05
- INBX 0.09
- Stochastic Oscillator
- WNEB 37.04
- INBX 71.11
About WNEB Western New England Bancorp Inc.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the Company's revenues, profits, and assets are derived by the Bank from banking products and services.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.